DK0885220T3 - Tropanderivater, deres fresmtilling og anvendelse - Google Patents

Tropanderivater, deres fresmtilling og anvendelse

Info

Publication number
DK0885220T3
DK0885220T3 DK97903355T DK97903355T DK0885220T3 DK 0885220 T3 DK0885220 T3 DK 0885220T3 DK 97903355 T DK97903355 T DK 97903355T DK 97903355 T DK97903355 T DK 97903355T DK 0885220 T3 DK0885220 T3 DK 0885220T3
Authority
DK
Denmark
Prior art keywords
disorders
derivatives
fresmation
application
monoamine neurotransmitter
Prior art date
Application number
DK97903355T
Other languages
Danish (da)
English (en)
Inventor
Joergen Scheel-Krueger
Peter Moldt
Frank Waetjen
Original Assignee
Neurosearch As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Neurosearch As filed Critical Neurosearch As
Application granted granted Critical
Publication of DK0885220T3 publication Critical patent/DK0885220T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D451/00Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
    • C07D451/02Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/468-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16Anti-Parkinson drugs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/30Drugs for disorders of the nervous system for treating abuse or dependence
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/30Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/36Opioid-abuse
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/04Anorexiants; Antiobesity agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D451/00Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurosurgery (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Psychiatry (AREA)
  • Addiction (AREA)
  • Diabetes (AREA)
  • Child & Adolescent Psychology (AREA)
  • Pain & Pain Management (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychology (AREA)
  • Emergency Medicine (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DK97903355T 1996-02-22 1997-02-21 Tropanderivater, deres fresmtilling og anvendelse DK0885220T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DK19496 1996-02-22
PCT/EP1997/000850 WO1997030997A1 (en) 1996-02-22 1997-02-21 Tropane-derivatives, their preparation and use

Publications (1)

Publication Number Publication Date
DK0885220T3 true DK0885220T3 (da) 2001-10-15

Family

ID=8090830

Family Applications (1)

Application Number Title Priority Date Filing Date
DK97903355T DK0885220T3 (da) 1996-02-22 1997-02-21 Tropanderivater, deres fresmtilling og anvendelse

Country Status (32)

Country Link
US (3) US6288079B1 (ru)
EP (2) EP0885220B1 (ru)
JP (1) JP3238414B2 (ru)
KR (1) KR100446571B1 (ru)
CN (1) CN1077574C (ru)
AT (1) ATE203023T1 (ru)
AU (1) AU720358B2 (ru)
BG (1) BG63945B1 (ru)
BR (1) BR9707636A (ru)
CA (1) CA2244773C (ru)
CZ (1) CZ287007B6 (ru)
DE (1) DE69705608T2 (ru)
DK (1) DK0885220T3 (ru)
EE (1) EE04751B1 (ru)
ES (1) ES2159839T3 (ru)
GR (1) GR3036829T3 (ru)
HK (1) HK1018957A1 (ru)
HU (1) HU228356B1 (ru)
IL (1) IL125146A (ru)
IS (1) IS1824B (ru)
NO (1) NO318731B1 (ru)
NZ (1) NZ330886A (ru)
PL (1) PL185132B1 (ru)
PT (1) PT885220E (ru)
RU (1) RU2167876C2 (ru)
SG (1) SG99853A1 (ru)
SI (1) SI0885220T1 (ru)
SK (1) SK281813B6 (ru)
TR (1) TR199801641T2 (ru)
UA (1) UA49872C2 (ru)
WO (1) WO1997030997A1 (ru)
ZA (1) ZA971525B (ru)

Families Citing this family (76)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2356225T3 (es) * 1998-09-30 2011-04-06 Nihon Medi-Physics Co., Ltd. Procedimiento para producir un derivado de ácido tropinona-monocarboxílico ópticamente activo.
AUPP627498A0 (en) 1998-10-02 1998-10-22 University Of Queensland, The Novel peptides - i
JP2005508872A (ja) * 2001-05-23 2005-04-07 ニューロサーチ、アクティーゼルスカブ トロパン誘導体及びこれをモノアミン神経伝達物質再取り込み阻害剤として使用する方法
KR20030030817A (ko) * 2001-10-11 2003-04-18 프레지던트 앤드 펠로우즈 오브 하바드 칼리지 세로토닌 운반 억제제
AU2002348135A1 (en) * 2001-10-31 2003-05-12 Recovery Pharmaceuticals, Inc. Methods for the treatment of addiction
JP2005511639A (ja) * 2001-11-30 2005-04-28 ニューロサーチ、アクティーゼルスカブ 虚血性疾患の治療用ドパミン再取り込み阻害活性を有するトロパン誘導体
US7459464B2 (en) 2002-05-30 2008-12-02 Neurosearch A/S Triple monoamine reuptake inhibitors for the treatment of chronic pain
US7560562B2 (en) 2002-11-01 2009-07-14 Neurosearch A/S Piperidine derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
WO2004050688A1 (en) 2002-12-02 2004-06-17 Xenome Ltd NOVEL χ-CONOTOXIN PEPTIDES (-II)
ATE547424T1 (de) 2002-12-02 2012-03-15 Xenome Ltd Chi-conotoxinpeptide mit einer n-terminalen pyroglutaminsäure
WO2004072075A1 (en) 2003-02-12 2004-08-26 Neurosearch A/S Novel 8-aza-bicyclo[3.2.1]octane derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
CN100372850C (zh) * 2003-02-12 2008-03-05 神经研究公司 新的8-氮杂-双环[3.2.1]辛烷衍生物和它们作为单胺神经递质再摄取抑制剂的用途
CN100551924C (zh) * 2003-02-12 2009-10-21 神经研究公司 8-氮杂-双环[3.2.1]辛烷衍生物和它们作为单胺神经递质再摄取抑制剂的用途
AU2004212166B2 (en) 2003-02-12 2010-07-29 Neurosearch A/S 8-aza-bicyclo (3.2.1) octane derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
KR20060030482A (ko) * 2003-06-24 2006-04-10 뉴로서치 에이/에스 신규한 8-아자-바이사이클로[3.2.1]옥탄 유도체 및모노아민 신경전달물질 재흡수 억제제로서의 이의 용도
AR045141A1 (es) * 2003-07-31 2005-10-19 Neurosearch As Sales de tartrato de 2- metoximetil-3-(3,4-diclorofenil)-8-azabiciclo (3,2,1) octano. composiciones farmaceuticas que los contienen y usos de las mismas.
US7309790B2 (en) 2003-10-03 2007-12-18 Pfizer Inc Chemical compounds
JP2007508336A (ja) * 2003-10-16 2007-04-05 ニューロサーチ、アクティーゼルスカブ モノアミン神経伝達物質再取り込みインヒビター及びアセチルコリンエステラーゼインヒビターを含む医薬組成物
KR20060125805A (ko) * 2003-11-18 2006-12-06 베링거 인겔하임 인터내셔날 게엠베하 고체 약제학적 제제 형태
WO2005070428A1 (en) * 2004-01-22 2005-08-04 Boehringer Ingelheim International Gmbh Pharmaceutical composition comprising a monoamine neurotransmitter re-uptake inhibitor and a dopamine agonist
CA2553649A1 (en) 2004-01-22 2005-08-04 Neurosearch A/S Compounds for the sustained reduction of body weight
AU2005205882A1 (en) * 2004-01-22 2005-08-04 Neurosearch A/S Pharmaceutical composition comprising a monoamine neurotransmitter re-uptake inhibitor and an N-methyl-D-aspartate (NMDA) receptors antagonist
DE102004004965B4 (de) * 2004-01-31 2006-01-05 Boehringer Ingelheim Pharma Gmbh & Co. Kg Verfahren zur Herstellung eines 2-(Ethoxymethyl)-tropanderivates
EP1755602A1 (en) * 2004-06-04 2007-02-28 Neurosearch A/S Monoamine neurotransmitter re-uptake inhibitor for the inhibition of beta-amyloid (a beta 40 and a beta 42) generation
EP1761527A1 (en) * 2004-06-18 2007-03-14 Neurosearch A/S Novel 9-aza-bicyclo¬3.3.1|nonane derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
US7524958B2 (en) 2004-06-18 2009-04-28 Neurosearch A/S Certain 9-aza-bicyclo[3.3.1] nonane derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
CA2570075A1 (en) 2004-06-18 2005-12-29 Neurosearch A/S Alkyl substituted piperidine derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
RU2382040C2 (ru) * 2004-09-30 2010-02-20 НьюроСёрч А/С Новые хромен-2-оновые производные и их применение в качестве ингибиторов обратного захвата моноаминовых нейромедиаторов
MX2007002384A (es) 2004-09-30 2007-05-11 Neurosearch As Nuevos derivados de cromen-2-ona y su uso como inhibidores de la reabsorcion del neurotransmisor de monoamina.
DE602006007550D1 (de) 2005-02-10 2009-08-13 Neurosearch As Alkylsubstituierte homopiperazinderivate und deren verwendung als monoamin neurotransmitter wiederaufnahmeinhibitoren
JP2008534650A (ja) * 2005-04-04 2008-08-28 ノイロサーチ アクティーゼルスカブ 新規置換ジアザビシクロ誘導体及びモノアミン神経伝達物質再取り込み阻害剤としてのそれらの使用
US20090137625A1 (en) 2005-04-08 2009-05-28 Dan Peters Novel Enantiomers and Their Use as Monoamine Neurotransmitter Re-Uptake Inhibitors
US7943630B2 (en) * 2005-06-28 2011-05-17 Neurosearch A/S 3,9-diaza-spiro[5.5]undecane derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
ATE481386T1 (de) * 2005-06-28 2010-10-15 Neurosearch As Neue 3-aza-spiroä5.5üundec-8-en derivate und deren verwendung als inhibitoren der wiederaufnahme von monoaminneurotransmittern
JP2008546827A (ja) * 2005-06-28 2008-12-25 ノイロサーチ アクティーゼルスカブ 新規な3−アザ−スピロ[5.5]ウンデカ−8−エン誘導体及びモノアミン神経伝達物質再取り込み阻害剤としてのこれらの使用
WO2007000465A1 (en) * 2005-06-28 2007-01-04 Neurosearch A/S Novel 3-aza-spiro[5.5]undecane derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
JP2009500440A (ja) * 2005-07-12 2009-01-08 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 性欲障害治療用医薬組成物
GEP20125566B (en) 2005-07-15 2012-07-10 Amr Technology Inc Aryl-and heteroaryl-substituded tetrahydro-benzazepines and use thereof to block reuptake of norepinephrine, dopamine and serotonin
CA2620418C (en) * 2005-08-24 2014-04-22 Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services Benztropine compounds and uses thereof
WO2007028769A1 (en) * 2005-09-05 2007-03-15 Neurosearch A/S Monoamine neurotransmitter re-uptake inhibitor for neuroprotection
WO2007028770A1 (en) * 2005-09-05 2007-03-15 Neurosearch A/S Monoamine neurotransmitter re-uptake inhibitors for neuroprotection in patients suffering from an advanced stage of a mental disease
EP1779851A1 (en) * 2005-10-31 2007-05-02 Boehringer Ingelheim Pharma GmbH & Co.KG Treatment of diabetes
TW200804367A (en) * 2005-11-11 2008-01-16 Neurosearch As Novel compounds
WO2007090886A1 (en) 2006-02-10 2007-08-16 Neurosearch A/S 3,9-diazabicyclo[3.3.1]nonane derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
TW200800980A (en) 2006-02-17 2008-01-01 Neurosearch As Novel compounds
WO2008028903A2 (en) 2006-09-04 2008-03-13 Neurosearch A/S Pharmaceutical combinations of a nicotine receptor modulator and a cognitive enhancer
US7691893B2 (en) * 2006-09-11 2010-04-06 Glaxo Group Limited Chemical compounds
GB0703998D0 (en) * 2007-03-01 2007-04-11 Glaxo Group Ltd Novel salt
TW200904815A (en) 2007-05-09 2009-02-01 Neurosearch As Novel compounds
WO2009034042A1 (en) * 2007-09-10 2009-03-19 Neurosearch A/S Novel benzooxazol- and benzooxathiol-2-one derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
JP2010539075A (ja) * 2007-09-10 2010-12-16 ノイロサーチ アクティーゼルスカブ フェノキサジン−3−オンの新規誘導体、並びにモノアミン神経伝達物質再取り込み阻害剤としてのその使用
WO2009065846A1 (en) * 2007-11-20 2009-05-28 Neurosearch A/S A method for treating addiction
US20110118304A1 (en) * 2007-11-20 2011-05-19 Neurosearch A/S Method for treating over-eating disorders
PE20120373A1 (es) 2009-05-12 2012-05-17 Albany Molecular Res Inc 7-([1,2,4]triazolo[1,5-a]piridin-6-il)-4-(3,4-diclorofenil)-1,2,3,4-tetrahidroisoquinolina
WO2010132487A1 (en) 2009-05-12 2010-11-18 Bristol-Myers Squibb Company CRYSTALLINE FORMS OF (S)-7-([1,2,4]TRIAZOLO[1,5-a]PYRIDIN-6-YL)-4-(3,4-DICHLOROHPHENYL)-1,2,3,4-TETRAHYDROISOQUINOLINE AND USE THEREOF
EP2430020B1 (en) 2009-05-15 2013-10-09 Aniona ApS Chromen-2-one derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
US20120220604A1 (en) 2009-09-21 2012-08-30 Neurosearch A/S Piperazinyl-alkyl-benzoimidazol-2-one derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
WO2011092061A1 (en) 2010-01-29 2011-08-04 Neurosearch A/S Chromen-2-one derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
WO2011117289A1 (en) 2010-03-25 2011-09-29 Neurosearch A/S Chromen-2-one derivatives and their use as monoamine neuro-transmitter re-uptake inhibitors
US8153653B2 (en) * 2010-06-22 2012-04-10 Hoffmann-La Roche Inc. Amido-tropane derivatives
WO2012000881A1 (en) 2010-07-02 2012-01-05 Neurosearch A/S Chromen-2-one derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
WO2012024397A2 (en) 2010-08-17 2012-02-23 Albany Molecular Research, Inc. 2,5-methano-and 2,5-ethano-tetrahydrobenzazepine derivatives and use thereof to block reuptake of norepinephrine, dopamine, and serotonin
EP2625170A1 (en) 2010-10-07 2013-08-14 Takeda Pharmaceutical Company Limited 1,4-oxazepane derivatives
CN108853071A (zh) 2012-02-16 2018-11-23 萨尼奥纳有限责任公司 用于联合治疗的药物组合物
EA033298B1 (ru) 2015-03-03 2019-09-30 Саниона А/С Комбинированная лекарственная форма тезофензина и метопролола
EA026727B1 (ru) * 2015-09-10 2017-05-31 Замертон Холдингс Лимитед Соль (1r,2r,3s)-3-(3,4-дихлорфенил)-2-(этоксиметил)-8-метил-8-азабицикло[3.2.1]октана и фталевой кислоты, способ её получения, продукт способа, фармацевтические композиции для лечения и/или профилактики нарушений, связанных с ожирением, их применение и способы лечения и/или профилактики нарушений, связанных с ожирением
EP3402473A1 (en) 2016-01-15 2018-11-21 Saniona A/S Tesofensine and metoprolol for treatment of hypertension
EA028995B1 (ru) * 2016-02-25 2018-01-31 Замертон Холдингс Лимитед Соль тезофензина и оптически активных ацетиламинокислот, их применение для лечения и/или профилактики нарушений, связанных с ожирением
RU2019109050A (ru) * 2016-09-07 2020-10-08 Саниона А/С Композиции тезофензина
DE102017210141A1 (de) 2017-06-16 2018-12-20 Henkel Ag & Co. Kgaa Portion zur Bereitstellung tensidhaltiger Flotten
WO2020144146A1 (en) 2019-01-07 2020-07-16 Saniona A/S Tesofensine for reduction of body weight in prader-willi patients
MX2022013236A (es) 2020-04-22 2023-01-24 Saniona As Tratamiento de la obesidad hipotalamica.
TWI772928B (zh) * 2020-10-21 2022-08-01 行政院原子能委員會核能研究所 非放射性標準品β-CFT之製備方法
WO2024008808A1 (en) 2022-07-08 2024-01-11 Initiator Pharma A/S Compound for treatment of female sexual dysfunction
CN115572289A (zh) * 2022-10-24 2023-01-06 龙曦宁(上海)医药科技有限公司 一种特索芬辛的合成方法
WO2024089247A1 (en) 2022-10-28 2024-05-02 Initiator Pharma A/S Compound for treatment of pain

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4281130A (en) 1979-05-24 1981-07-28 Sterling Drug Inc. Lower-alkyl 4,6,7,8,8a-9-hexahydro-6,9-ethanothieno[3,2-f]indolizine-10-carboxylate
US5380848A (en) * 1990-08-09 1995-01-10 Research Triangle Institute Cocaine receptor binding ligands
US5496953A (en) 1990-08-09 1996-03-05 Research Triangle Institute Cocaine receptor binding ligands
US5128118A (en) * 1990-08-09 1992-07-07 Research Triangle Institute Cocaine receptor binding ligands
DE69233656D1 (de) * 1991-11-15 2006-10-19 Res Triangle Inst Kokain-Rezeptor Bindungsliganden
AU672052B2 (en) * 1992-12-23 1996-09-19 Neurosearch A/S Antidepressant and antiparkinsonian compounds
AU672644B2 (en) 1992-12-23 1996-10-10 Neurosearch A/S Aryl substituted heterocyclic compounds
AU671163B2 (en) 1992-12-23 1996-08-15 Neurosearch A/S Alkyl substituted heterocyclic compounds
CZ284379B6 (cs) * 1994-04-19 1998-11-11 Neurosearch A/S Tropanové deriváty, způsob jejich přípravy a jejich použití
GB9626611D0 (en) * 1996-12-20 1997-02-05 Unilever Plc Agglomerated silicas

Also Published As

Publication number Publication date
HU228356B1 (en) 2013-03-28
NO983877D0 (no) 1998-08-21
TR199801641T2 (xx) 1998-11-23
CA2244773C (en) 2006-01-03
AU720358B2 (en) 2000-06-01
BR9707636A (pt) 1999-07-27
NZ330886A (en) 1999-02-25
DE69705608D1 (de) 2001-08-16
SI0885220T1 (en) 2001-12-31
SG99853A1 (en) 2003-11-27
DE69705608T2 (de) 2002-05-16
CA2244773A1 (en) 1997-08-28
IL125146A0 (en) 1999-01-26
WO1997030997A1 (en) 1997-08-28
EP0885220A1 (en) 1998-12-23
CN1077574C (zh) 2002-01-09
HUP9901199A3 (en) 2001-02-28
HUP9901199A2 (hu) 1999-08-30
PT885220E (pt) 2001-11-30
NO318731B1 (no) 2005-05-02
UA49872C2 (ru) 2002-10-15
RU2167876C2 (ru) 2001-05-27
SK281813B6 (sk) 2001-08-06
PL185132B1 (pl) 2003-02-28
CZ287007B6 (en) 2000-08-16
US6395748B2 (en) 2002-05-28
ZA971525B (en) 1997-10-21
KR19990087127A (ko) 1999-12-15
HK1018957A1 (en) 2000-01-14
NO983877L (no) 1998-08-21
KR100446571B1 (ko) 2004-11-03
CN1211982A (zh) 1999-03-24
BG63945B1 (bg) 2003-07-31
CZ252098A3 (cs) 1998-11-11
ES2159839T3 (es) 2001-10-16
SK92998A3 (en) 1998-11-04
US20020128284A1 (en) 2002-09-12
US20010018444A1 (en) 2001-08-30
ATE203023T1 (de) 2001-07-15
BG102637A (en) 1999-06-30
PL328503A1 (en) 1999-02-01
JP2000504739A (ja) 2000-04-18
IL125146A (en) 2002-03-10
EP1130020A1 (en) 2001-09-05
IS4825A (is) 1998-08-17
EE9800254A (et) 1999-02-15
GR3036829T3 (en) 2002-01-31
US6288079B1 (en) 2001-09-11
IS1824B (is) 2002-10-01
AU1794097A (en) 1997-09-10
JP3238414B2 (ja) 2001-12-17
EE04751B1 (et) 2006-12-15
EP0885220B1 (en) 2001-07-11

Similar Documents

Publication Publication Date Title
DK0885220T3 (da) Tropanderivater, deres fresmtilling og anvendelse
IS2164B (is) ß2-adrenvirk viðtaka gerandefni
ATE446286T1 (de) Piperidin mch antagonisten und ihre verwendung in der behandlung von obesität und störungen des zentralnervensystems
MX2009003183A (es) Derivados de sulfonilpirazolincarboxamidina como antagonistas de 5-ht6.
HRP20080262T3 (en) 4-(2-phenyloxyphenyl)-piperidine or -1,2,3,6-tetrahydropyridine derivatives as serotonin reuptake inhibitors
PH12013502376B1 (en) Arylsulfonyl pyrazoline carboxamidine derivatives as 5-ht6 antagonists
MXPA05003734A (es) Inhibidores de acetilcolinesterasa en el sitio de enlace dual para el tratamiento de la enfermedad de alzheimer.
MX2009005509A (es) 2-aminoquinolina como los antagonistas de los receptores 5-hidroxitriptamina 5a (5-ht5a).
WO2007058805A3 (en) Compositions and methods for treating cns disorders
DE502004011551D1 (de) 1,3,4-substituierte pyrazole als 5-ht rezeptor-antagonisten zur behandlung von psychosen und neurologischen störungen
NO20092688L (no) Forbindelser med en kombinasjon av cannabinoid-CB1 antagonisme og acetylcholinesteraseinhibering
ATE452134T1 (de) Zur behandlung von auf eine modulation des dopamin-d3-rezeptors ansprechende erkrankungen geeignete 4-piperazinylpyrimidinverbindungen
ATE334989T1 (de) Antidepressive azaheterocyclylmethyl-derivate von 2,3-dihydro-1,4-dioxino 2,3-föchinoxalin
DE602006015193D1 (de) 8-alk0xy-4-methyl-3, 4-dihydr0-chinaz0lin-2-yl-amine und ihre verwendung als 5-ht5a-rezeptor-liganden
UA81469C2 (en) 4-(2-phenyloxyphenyl)-piperidine or -1,2,3,6-tetrahydropyridine derivatives as serotonin reuptake inhibitors
CA2521030A1 (en) 4-(2-phenyloxyphenyl)-piperidine or -1,2,3,6-tetrahydropyridine derivatives as serotonin reuptake inhibitors
UA98122C2 (ru) Производные сульфонилпиразол и сульфонилпиразолон карбоксамидина как антагонисты рецепторов 5-ht6
WO2000071533A3 (en) 1,4-dithiin and 1,4-dithiepin- 1,1,4,4, tetroxide derivatives useful as antagonists of the human galanin receptor